Diabetes & Blood Sugar lab tests

The American Diabetes Association recommends screening every adult from age 35, repeated every three years when results are normal, and starting earlier or testing more often with excess weight plus any other risk factor: a parent or sibling with diabetes, high blood pressure, low HDL or high triglycerides, a history of gestational diabetes, polycystic ovary syndrome, or a background with higher diabetes rates. Anyone with a previous prediabetes result is tested every year.

Symptoms are a reason to test now rather than at the next interval: unusual thirst, passing urine more often (especially at night), blurred vision, slow-healing cuts, unexplained weight loss, or tiredness that does not lift. Prediabetes usually has no symptoms at all, which is why screening by age and risk matters more than waiting to feel something.

A1c is the right first test for most people: it needs no fasting, it is not thrown off by one stressful morning or a late dinner, and the diagnostic cut-points are the same everywhere. Its weakness is that it reads red blood cells, so anemia, iron deficiency, a hemoglobin variant, recent blood loss or a transfusion, kidney disease and pregnancy can all push it up or down; in those situations fasting glucose is the better anchor and is often ordered alongside.

Fasting insulin, read with fasting glucose as HOMA-IR, is the test for the stage before prediabetes. Insulin resistance means the pancreas is producing more insulin to hold glucose in range; glucose and A1c stay normal while insulin climbs, sometimes for a decade. People with extra weight around the middle, a family history, high triglycerides or a history of gestational diabetes often want this earlier signal, and it is the number that moves first when diet, activity or weight changes.

C-peptide is released in equal amounts with the body's own insulin, so it shows how much insulin the pancreas is still making. Clinicians use it to tell type 1 from type 2 diabetes, to assess residual insulin production, and — because injected insulin contains no C-peptide — to measure a person's own output during insulin therapy.

A1c below 5.7% is normal, 5.7–6.4% is prediabetes and 6.5% or higher is in the diabetes range; a diagnosis is confirmed by repeating the test or by a second abnormal test. Fasting glucose under 100 mg/dL is normal, 100–125 mg/dL is impaired fasting glucose (prediabetes) and 126 mg/dL or above on two occasions is diagnostic. A1c also converts to an estimated average glucose — 6% is about 126 mg/dL and 7% about 154 mg/dL — which is the number the eAG calculator below reports.

HOMA-IR has no single universal cut-point; values above roughly 2.0–2.5 are commonly read as insulin resistance, and the trend over repeat tests is more informative than one reading. A high fasting insulin with a normal glucose is the classic early pattern. A low C-peptide with high glucose points toward type 1 or late type 2; a high C-peptide with high glucose points toward insulin resistance. Every result is interpreted against your history, so the portal shows each value against its reference range and your clinician makes the call.

Three free tools turn the raw numbers into the figures clinicians quote: the HOMA-IR calculator (fasting insulin and fasting glucose), the TyG index calculator (fasting triglycerides and glucose, an insulin-resistance estimate from a lipid panel and a CMP), and the eAG calculator (A1c to estimated average glucose). Each links back to the test that produces the inputs.